Crescendo Biologics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH194673D
- Pages: 24
- November 2018
- Total Views:1237
- Region : Europe
- GlobalData
- Equity Research Report

Details
Summary
Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company's pipeline includes humabody programs targeting oncology. It practises in the antibody discoveries and development, which include CAT, medimmune, morphosys and GSK. Crescendo develops a transformational Humabody-based topical biologic for psoriasis, which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The company's oncology programmes produce novel therapeutics that capitalizes on advantages of the Humabody VH format. Crescendo is headquartered in Cambridge, the UK.
Crescendo Biologics Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Crescendo Biologics Raises USD69.1 Million in Series B Venture Financing 10
Crescendo Biologics Raises Funds through Venture Financing 12
Crescendo Biologics Raises USD 3.3 Million In Series A Financing 13
Crescendo Biologics Raises USD 28 Million In Series A Financing 14
Licensing Agreements 16
Takeda Pharma Exercises Option for Licensing Agreement with Crescendo Biologics 16
Zai Lab Enters into Licensing Agreement with Crescendo Biologics 17
Crescendo Biologics Ltd-Key Competitors 18
Crescendo Biologics Ltd-Key Employees 19
Crescendo Biologics Ltd-Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jun 14, 2017: Crescendo Biologics Appoints Edward J. Stewart as Chief Business Officer 21
Apr 03, 2017: Crescendo Biologics Appoints Philip Bland-Ward as Chief Scientific Officer 22
Other Significant Developments 23
Aug 15, 2018: Crescendo Biologics reaches technical milestone for a second target in strategic collaboration with Takeda 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List Of Figure
List of Figures
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crescendo Biologics Raises USD69.1 Million in Series B Venture Financing 10
Crescendo Biologics Raises Funds through Venture Financing 12
Crescendo Biologics Raises USD 3.3 Million In Series A Financing 13
Crescendo Biologics Raises USD 28 Million In Series A Financing 14
Takeda Pharma Exercises Option for Licensing Agreement with Crescendo Biologics 16
Zai Lab Enters into Licensing Agreement with Crescendo Biologics 17
Crescendo Biologics Ltd, Key Competitors 18
Crescendo Biologics Ltd, Key Employees 19
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Crescendo Biologics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company's pipeline includes humabody programs targeting oncology. It practises in the antibody discoveries and development, which include CAT, medimmune, morphosys and GSK. Crescendo develops a transformational Humabody-based topical biologic for psoriasis, which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The company's oncology programmes produce novel therapeutics that capitalizes on advantages of the Humabody VH format. Crescendo is headquartered in Cambridge, the UK.
Crescendo Biologics Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Crescendo Biologics Raises USD69.1 Million in Series B Venture Financing 10
Crescendo Biologics Raises Funds through Venture Financing 12
Crescendo Biologics Raises USD 3.3 Million In Series A Financing 13
Crescendo Biologics Raises USD 28 Million In Series A Financing 14
Licensing Agreements 16
Takeda Pharma Exercises Option for Licensing Agreement with Crescendo Biologics 16
Zai Lab Enters into Licensing Agreement with Crescendo Biologics 17
Crescendo Biologics Ltd-Key Competitors 18
Crescendo Biologics Ltd-Key Employees 19
Crescendo Biologics Ltd-Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jun 14, 2017: Crescendo Biologics Appoints Edward J. Stewart as Chief Business Officer 21
Apr 03, 2017: Crescendo Biologics Appoints Philip Bland-Ward as Chief Scientific Officer 22
Other Significant Developments 23
Aug 15, 2018: Crescendo Biologics reaches technical milestone for a second target in strategic collaboration with Takeda 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List Of Figure
List of Figures
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crescendo Biologics Raises USD69.1 Million in Series B Venture Financing 10
Crescendo Biologics Raises Funds through Venture Financing 12
Crescendo Biologics Raises USD 3.3 Million In Series A Financing 13
Crescendo Biologics Raises USD 28 Million In Series A Financing 14
Takeda Pharma Exercises Option for Licensing Agreement with Crescendo Biologics 16
Zai Lab Enters into Licensing Agreement with Crescendo Biologics 17
Crescendo Biologics Ltd, Key Competitors 18
Crescendo Biologics Ltd, Key Employees 19
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Crescendo Biologics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.